Last update 22 Feb 2025

Irinotecan Hydrochloride Lioposome (Ouyi)

Overview

Basic Info

Drug Type
Small molecule drug, Liposomal Drug
Synonyms
Irinotecan Liposome, Nanoliposomal Irinotecan, 伊立替康纳米脂质体
+ [2]
Target
Top I
Mechanism
TOP1 inhibitors(DNA topoisomerase I inhibitors)
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease+ [1]
Active Indication
Metastatic Pancreatic CancerPancreatic Ductal AdenocarcinomaBiliary Tract Neoplasms+ [1]
Inactive Indication
Advanced biliary tract cancerSmall Cell Lung Cancer
Originator Organization
CSPC Ouyi Pharmaceutical Co., Ltd.CSPC Ouyi Pharmaceutical Co., Ltd.
Active Organization
CSPC Ouyi Pharmaceutical Co., Ltd.CSPC Ouyi Pharmaceutical Co., Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
CN (15 Sep 2023),
Metastatic Pancreatic Cancer
Regulation-
Login to view timeline

Related

23
Clinical Trials associated with Irinotecan Hydrochloride Lioposome (Ouyi)
ChiCTR2400094119
/ SuspendedPhase 4IIT
Single-arm, multicenter, exploratory clinical study of irinotecan liposomes combined with oxaliplatin and 5-Fu/Lv in second-line treatment of locally advanced or metastatic pancreatic cancer
ChiCTR2400092084
/ SuspendedPhase 1IIT
Phase I clinical study of irinotecan liposome combined with furoquininib in the third-line and beyond patients with advanced colorectal cancer
ChiCTR2400091274
/ SuspendedPhase 2IIT
Clinical study of Irinotecan liposomes combined with Tigorgone for the treatment of patients with advanced metastatic pancreatic cancer with liver metastasis of second line and above
100 Clinical Results associated with Irinotecan Hydrochloride Lioposome (Ouyi)
Login to view more data
100 Translational Medicine associated with Irinotecan Hydrochloride Lioposome (Ouyi)
Login to view more data
100 Patents (Medical) associated with Irinotecan Hydrochloride Lioposome (Ouyi)
Login to view more data
100 Deals associated with Irinotecan Hydrochloride Lioposome (Ouyi)
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
L01XX19
-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Metastatic Pancreatic Cancer
CN
CSPC Ouyi Pharmaceutical Co., Ltd.CSPC Ouyi Pharmaceutical Co., Ltd.
15 Sep 2023
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pancreatic Ductal AdenocarcinomaPhase 3-
CSPC Ouyi Pharmaceutical Co., Ltd.CSPC Ouyi Pharmaceutical Co., Ltd.
01 Sep 2024
Biliary Tract NeoplasmsPhase 2
CN
CSPC Ouyi Pharmaceutical Co., Ltd.CSPC Ouyi Pharmaceutical Co., Ltd.
30 Jun 2024
Advanced biliary tract cancerPhase 2
CN
CSPC Ouyi Pharmaceutical Co., Ltd.CSPC Ouyi Pharmaceutical Co., Ltd.
17 Dec 2021
Small Cell Lung CancerPhase 2
CN
CSPC Ouyi Pharmaceutical Co., Ltd.CSPC Ouyi Pharmaceutical Co., Ltd.
01 Apr 2021
Advanced breast cancerPhase 1
CN
CSPC Ouyi Pharmaceutical Co., Ltd.CSPC Ouyi Pharmaceutical Co., Ltd.
24 May 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free